HCi Viocare is creating the first independent, cross-border chain of full service prosthetic, orthotic and diabetic foot rehabilitation clinics in Europe. The clinics will operate according to British and International standards and provide truly indepencdent and personalized quality of care for its patients.

 

The first HCi Viocare clinic has been operating since September 2015 in Scotland, GlasgowHCi Viocare’s clinical care is headed up by Brian Maguire, a nationally recognized HCPC registered prosthetist/orthotist with an extensive NHS and private background. With a multidisciplinary team of experts, the clinic delivers the highest quality in personalized services and in products. The continuous update of technological know-how and practical expertise leads HCi Viocare to deliver a wide range of services and products to its clients including modular leg prosthesis systems, micro-processor controlled knees, robotic knee and angle systems and myoelectric arm prostheses. The 500m2 facility houses a fully equipped consultation and rehabilitation service provided with excellent comfort and functionality and also a state-of-the- art workshop, to provide rapid on-site manufacturing of prosthetic and orthotic solutions. 

 

The company intends to seek to improve people’s wellbeing in the face of a growing and correlated population of the obese, diabetic, amputated and/or movement impaired.

 

By 2050 the amputee

population will

more than double

Source: http://www.advancedamputees.com

 

The prosthetics and orthotics markets are very large, and yet the delivery of P&O services is very fragmented in Europe, unlike in the USA.

 

Est. global
prosthetics market
by 2017

Est. global
orthotics market
by 2017

 

 

A number of European regions, as well as the Middle East, are under-served in terms of quantity and quality. Importantly, many practicing prosthetists are not appropriately skilled. 

 

The company is researching other opportunities for organic or inorganic growth in Europe and would welcome approached by potential JV partners in the Middle East.